Global Pharmaceutical Excipient Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Organic Chemicals, Oleochemicals- Fatty Alcohols, Mineral Stearates,Glycerin, Other Oleochemicals Carbohydrates- Sugars, Actual Sugars, Sugar Alcohols, Artificial Sweeteners Cellulose- Microcrystalline cellulose, Cellulose Ethers, Carboxymethyl Cellulose (CMC), and Croscarmellose Sodium Starch- Modified Starch, Dried Starch; Converted Starch Petrochemicals- Glycols, Povidones, Mineral Hydrocarbons, Acrylic Polymers, Other Petrochemical Excipients Proteins, Other Organic Chemicals, Artificial, Calcium Phosphate, Metal Oxides, Halites Calcium Carbonate, Calcium Sulphate, Other Artificial Chemicals, Other Chemicals.

By Technique;

Fillers & Diluents, Suspending & Viscosity, Coating, Binders, Flavoring & Sweeteners, Disintegrants Colorants, Lubricants & Glidants, Preservatives, Emulsifying.

By Formulation;

; Oral Formulations, Tablets, Capsules- Hard-gelatin Capsules, Soft-gelatin Capsules Liquid Formulations, Other Oral Formulations, Topical Formulations, Parenteral Formulations, Other Formulations.

By Application;

Taste Masking, Stabilizers, Modified-Release, Solubility & Bioavailability Enhancement, Others.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn764348420 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Pharmaceutical Excipient Market (USD Million), 2021 - 2031

In the year 2024, the Global Pharmaceutical Excipient Market was valued at USD 8,685.59 million. The size of this market is expected to increase to USD 13,675.72 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.7%.

The Global Pharmaceutical Excipient Market plays a crucial role in the pharmaceutical industry, as excipients are essential components in the formulation of drugs. These inactive substances serve as the vehicle or medium for delivering the active pharmaceutical ingredients (APIs) to the desired therapeutic site in the body. Excipients are used in a variety of dosage forms, including tablets, capsules, ointments, injectables, and suspensions. Their primary functions include enhancing the stability, bioavailability, and efficacy of the active drug, as well as ensuring proper drug release, texture, and taste. As the pharmaceutical industry grows in response to the increasing global demand for healthcare and medicines, the excipient market is evolving with innovations in excipient formulations, offering solutions for targeted drug delivery, controlled release, and personalized medicine.

The Global Pharmaceutical Excipient Market is witnessing substantial growth driven by several factors, including the increasing prevalence of chronic diseases, an aging population, and the expanding demand for generic drugs and biologics. The rising focus on personalized medicine and biopharmaceuticals is also fueling the growth of specialized excipients that can improve the delivery of novel therapeutics, such as biologics, gene therapies, and peptides. Additionally, the shift toward more patient-centric drug formulations is propelling the development of excipients that improve the convenience, safety, and efficacy of drug administration. As more drug manufacturers seek to enhance the performance of their formulations and meet the evolving needs of patients, excipients are becoming increasingly sophisticated, with greater attention to their compatibility with active ingredients and their role in regulatory compliance.

The market for pharmaceutical excipients is also influenced by advancements in technology and regulatory changes. Innovations such as nanotechnology, 3D printing, and advanced delivery systems are driving the development of new excipient solutions to meet the demands of modern drug formulations. Moreover, increasing regulatory scrutiny around the quality and safety of excipients is encouraging manufacturers to ensure compliance with stringent standards. Excipients must meet both pharmaceutical regulations and good manufacturing practices (GMP) to ensure drug safety and efficacy. With the global pharmaceutical market becoming more complex, excipient suppliers are focusing on providing high-quality, multifunctional excipients that can enhance the performance of drugs while complying with stringent regulatory standards. The increasing collaboration between pharmaceutical companies and excipient manufacturers will continue to drive the evolution of the excipient market, fostering new developments that will improve the effectiveness of pharmaceutical formulations across the globe.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Technique
    3. Market Snapshot, By Formulation
    4. Market Snapshot, By Application
    5. Market Snapshot, By Region
  4. Global Pharmaceutical Excipient Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing demand for generic drugs and biologics
        2. Increasing prevalence of chronic diseases and an aging population
        3. Advancements in personalized medicine and biopharmaceuticals
        4. Rising demand for targeted drug delivery and controlled-release formulations
        5. Technological innovations in excipient development (e.g., nanotechnology, 3D printing)
      2. Restraints
        1. Stringent regulatory requirements and quality control standards
        2. High cost of specialized excipients and development processes
        3. Limited availability of excipients with specific properties for novel drug formulations
        4. Risk of incompatibility between excipients and active pharmaceutical ingredients (APIs)
        5. Increasing concerns over the safety and toxicity of certain excipients
      3. Opportunities
        1. Growing focus on patient-centric drug formulations and convenience
        2. Expanding use of excipients in biologic and biosimilar drug development
        3. Potential for innovation in excipients for novel drug delivery systems
        4. Emerging markets offering untapped growth potential
        5. Increasing collaborations between pharmaceutical companies and excipient manufacturers for tailored solutions
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Pharmaceutical Excipient Market, By Type, 2021 - 2031 (USD Million)
      1. Organic Chemicals
      2. Oleochemicals
        1. Fatty Alcohols
        2. Mineral Stearates
        3. Glycerin
        4. Other Oleochemicals
      3. Carbohydrates
        1. Sugars
          1. Actual Sugars
          2. Sugar Alcohols
          3. Artificial Sweeteners
        2. Cellulose
          1. Microcrystalline cellulose
          2. Cellulose ethers
          3. Carboxymethyl cellulose (CMC) and croscarmellose sodium
          4. Cellulose esters
        3. Starch
          1. Modified Starch
          2. Dried Starch
          3. Converted Starch
      4. Petrochemicals
        1. Glycols
        2. Povidones
        3. Mineral Hydrocarbons
        4. Acrylic Polymers
        5. Other Petrochemical Excipients
      5. Proteins
      6. Other Organic Chemicals
      7. Artificial
      8. Calcium Phosphate
      9. Metal Oxides
      10. Halites
      11. Calcium Carbonate
      12. Calcium Sulphate
      13. Other Artificial Chemicals
      14. Other Chemicals
    2. Global Pharmaceutical Excipient Market, By Technique, 2021 - 2031 (USD Million)
      1. Fillers & Diluents
      2. Suspending & Viscosity
      3. Coating
      4. Binders
      5. Flavoring & Sweeteners
      6. Disintegrants
      7. Colorants
      8. Lubricants & Glidants
      9. Preservatives
      10. Emulsifying
    3. Global Pharmaceutical Excipient Market, By Formulation, 2021 - 2031 (USD Million)
      1. Oral Formulations
      2. Tablets
      3. Capsules
        1. Hard-gelatin Capsules
        2. Soft-gelatin Capsules
      4. Liquid Formulations
      5. Other Oral Formulations
      6. Topical Formulations
      7. Parenteral Formulations
      8. Other Formulations
    4. Global Pharmaceutical Excipient Market, By Application, 2021 - 2031 (USD Million)
      1. Taste Masking
      2. Stabilizers
      3. Modified-Release
      4. Solubility & Bioavailability Enhancement
      5. Others
    5. Global Pharmaceutical Excipient Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Ashland Global Holdings
      2. Croda International
      3. BASF SE
      4. Lubrizol Corporation
      5. Evonik Industries AG
      6. Associated British Foods
      7. Roquette Feres
      8. Archer Daniels Midland Company
      9. DuPont
      10. Avantor Performance Materials, Inc.
      11. The Dow Chemical Company
      12. FMC Corporation
      13. Evonik Industries
      14. Lubrizol Corporation
      15. Roquette
      16. Colorcon, Inc.
  7. Analyst Views
  8. Future Outlook of the Market